Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels

Detaylı Bibliyografya
Asıl Yazarlar:	Hopewell, J, Clarke, R, Seedorf, U, Farrall, M, Hamsten, A, Collins, R, Watkins, H, Consortium, PROCARDIS
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2010

Benzer Materyaller

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Oxidized phospholipids, Lp(a) and coronary heart disease risk
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
Yazar:: Kyriakou, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
Yazar:: Kyriakou, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Independent relevance of renal function for coronary artery disease
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
Yazar:: Parish, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Genetic Variants in Lp(a) Lipoprotein and Coronary Disease REPLY
Yazar:: Farrall, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Independent Relevance of Cytokines for Risk of Coronary Heart Disease
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP
Yazar:: Goel, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

LPA NULL MUTATION GENOTYPING AND QPCR ANALYSIS REFINE KRINGLE ISOFORM ANALYSIS OF LP(A) LEVELS
Yazar:: Kyriakou, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE
Yazar:: Seedorf, U, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Apolipoprotein proteomics for residual lipid-related risk in coronary heart disease
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Plasma lipoproteins: apolipoprotein structure and function.
Yazar:: R W Mahley, ve diğerleri
Baskı/Yayın Bilgisi: (1984-12-01)

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis
Yazar:: K. I. Tebloev, ve diğerleri
Baskı/Yayın Bilgisi: (2005-10-01)

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
Yazar:: Farrer, M, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Yazar:: Ruotolo, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Evidence from a family based study of gene association of lymphotoxin alpha with coronary artery disease (CAD)
Yazar:: Green, F, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
Yazar:: Dick C. Chan, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
Yazar:: R W Mahley, ve diğerleri
Baskı/Yayın Bilgisi: (1995-04-01)

A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein
Yazar:: Ferdinand M. van 't Hooft, ve diğerleri
Baskı/Yayın Bilgisi: (1999-09-01)

Influence of polyunsaturated fats on composition of plasma lipoproteins and apolipoproteins
Yazar:: G L Vega, ve diğerleri
Baskı/Yayın Bilgisi: (1982-08-01)

Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Yazar:: Björkegren, J, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Rat plasma lipoproteins and apolipoproteins in experimental hypothyroidism.
Yazar:: L Dory, ve diğerleri
Baskı/Yayın Bilgisi: (1981-02-01)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
Yazar:: Yahui Lin, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
Yazar:: G L Vega, ve diğerleri
Baskı/Yayın Bilgisi: (1984-06-01)

The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
Yazar:: Junfeng Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
Yazar:: Waldomiro Carlos Manfroi, ve diğerleri
Baskı/Yayın Bilgisi: (1999-06-01)

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
Yazar:: Kuo-Liong Chien, ve diğerleri
Baskı/Yayın Bilgisi: (2007-11-01)

Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
Yazar:: Anastasiya Matveyenko, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency
Yazar:: S Bijvoet, ve diğerleri
Baskı/Yayın Bilgisi: (1996-03-01)

Alterations in plasma lipoproteins and apolipoproteins in experimental allergic encephalomyelitis.
Yazar:: V G Shore, ve diğerleri
Baskı/Yayın Bilgisi: (1987-02-01)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
Yazar:: Karpe, F, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
Yazar:: F Karpe, ve diğerleri
Baskı/Yayın Bilgisi: (1994-07-01)

Sex-related differences in the concentrations of apolipoprotein E in human blood plasma and plasma lipoproteins.
Yazar:: N R Phillips, ve diğerleri
Baskı/Yayın Bilgisi: (1983-11-01)